Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 724.53M P/E - EPS this Y 108.90% Ern Qtrly Grth -
Income -398.71M Forward P/E -4.69 EPS next Y -118.80% 50D Avg Chg 7.00%
Sales 996.61M PEG 0.92 EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book N/A EPS next 5Y 37.90% 52W High Chg -87.00%
Recommedations 2.30 Quick Ratio 0.62 Shares Outstanding 147.30M 52W Low Chg 50.00%
Insider Own 4.99% ROA -16.32% Shares Float 122.46M Beta 1.97
Inst Own 50.52% ROE - Shares Shorted/Prior 31.40M/39.71M Price 8.40
Gross Margin 4.92% Profit Margin -40.01% Avg. Volume 6,289,924 Target Price 21.40
Oper. Margin -147.81% Earnings Date Aug 6 Volume 6,171,024 Change -4.06%
About Novavax, Inc.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc. News
07/25/24 The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
07/23/24 Novavax's (NVAX) Shares Surge 211% YTD: Time to Buy the Stock?
07/17/24 Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
07/16/24 Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
07/15/24 Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?
07/08/24 Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
07/07/24 Investors push Novavax (NASDAQ:NVAX) 6.0% lower this week, company's increasing losses might be to blame
07/03/24 Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
07/02/24 Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
07/01/24 Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
07/01/24 Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
06/29/24 Where Will Novavax Be in 1 Year?
06/28/24 Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
06/28/24 Meme Stock or Vaccine Stock? Novavax’s Identity Crisis and Why It Matters for Investors
06/25/24 Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
06/25/24 Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
06/25/24 Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine
06/24/24 Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
06/24/24 Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
06/20/24 Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
NVAX Chatroom

User Image Ochaye Posted - 2 minutes ago

$NVAX How about a NVAX ST's class action lawsuit against Left and any of his associates? Heck, let's sue the FDA and CDC, the SEC and even Biden's body doubles.

User Image JB9696 Posted - 38 minutes ago

$NVAX https://www.investopedia.com/why-the-sec-is-suing-short-seller-andrew-left-8684364

User Image stockflippper Posted - 42 minutes ago

$NVAX Andrew Left is ordered to return all the profit he earned from shorting all stocks listed. JJ must file a lawsuit to make shorts pay for the damage they caused in the last three years!

User Image Darby53 Posted - 1 hour ago

$BBAI $NVDA $NVAX you are in all the right securities that's for sure 😊

User Image Tenzen70 Posted - 1 hour ago

$BBAI Have been busy the last few weeks but check in on the port when the net allows. Am full as limit orders hit $BBAI $NVDA $NVAX and a few others which I am constantly accumulating … Pissed I have missed the recent volatility for the futures side of things. Trade less , enjoy life more and somehow make more money along the way ! Wish I figured that out 20 years ago

User Image Jeffmeister2005 Posted - 1 hour ago

$NVAX $25+ @ earnings report..... exciting!!! $25!

User Image FireBird123 Posted - 1 hour ago

$NVAX Everyone laugh at this cuntt. He mad I made money on NVAX hahahaha

User Image eennels0157 Posted - 1 hour ago

$NVAX You are so short sighted and clearly uninformed! Read the positive press releases over the last month and watch the videos to educate yourself. NVAX is the real deal with FDA (US), EMA (Europe), and Canada authorization of its vaccine imminent which will lead to a massive distribution and exponential increase in revenue for the company. Since the beginning of July the stock price climbed from a low of $11.76 to a high of almost $17. That's a 45% increase. NICE TRY...NOT SELLING...Buying and holding for the Gold!

User Image Darby53 Posted - 2 hours ago

$NVAX screenshot taken 👍 thanks for being so... helpful and caring about the health of the world 🌎

User Image Ochaye Posted - 2 hours ago

$NVAX The beautiful lull The dangerous tug We get to feel small But not out of place at all https://www.youtube.com/watch?v=F6bRuOyJTVo

User Image FireBird123 Posted - 2 hours ago

$NVAX It's been a fabulous 3 months. The best part is that the party is barely starting. The stock market doesn't reward the frail-minded and impatient souls. All the bearish comments are comedy gold to me. This stock will make me a millionaire. Then the next million will come much easier, etc etc.. fck the 9 to 5 rat race, and fck you for thinking your bearish comments affect my rock-hard pen!s for NVAX.

User Image FireBird123 Posted - 2 hours ago

$NVAX @VMAESA Where the fck are you, you stup!d ugly fck? Come back here clown. 🤡 You think you're the ssshit because you keep posting that nailed it GIF and saying thousands of your bots are gey alongside with you. Loser. Scam cult. F out of here🖕

User Image eennels0157 Posted - 3 hours ago

$NVAX Novavax expects revenue between $970 million and $1.2 billion for the year! https://finance.yahoo.com/news/where-novavax-1-125500658.html A recent GLOBAL partnership with Sanofi, a much larger biotech, has strengthened NVAX balance sheet. Sanofi made an up-front payment of $500 million to Novavax. In exchange, the France-based biotech obtained the right to commercialize Nuvaxovid world wide. Novavax's COVID vaccine are in 175+ countries worldwide. The deal allows Sanofi to develop combination vaccines using Nuvaxovid, including a flu/Covid shot. For each new product, Novavax will receive additional launch and sales milestones of up to $200 million plus ongoing product royalties. Santos also got the license to use the biotech's adjuvant technology to boost vaccine efficacy. Novavax will be entitled to development and regulatory milestones of up to $700 million related to vaccines that use its adjuvant technology, in addition to potential royalties. Lastly, Sanofi acquired a 4.9% stake in Novavax for $70 million.

User Image eennels0157 Posted - 3 hours ago

$NVAX NOVAVAX FINANCIAL OUTLOOK IS BRIGHT 🌞 🚀 Novavax is due to report earnings August 6 and is expected to turn a profit in the second quarter as sales accelerate sequentially. 60% NVAX shares held by institutional investors, 7.5% with insiders. Analysts and investors alike will be keeping a close eye on the performance of Novavax in its upcoming earnings disclosure. Novavax is expected to turn a profit in the second quarter as sales accelerate sequentially. Revenue is estimated to be $429.83 million, indicating a 1.27% growth compared to the corresponding quarter of the prior year. For the annual period, the Zacks Consensus Estimates anticipate a revenue of $999.14 million, signifying shifts of +1.57% from the last year. Based on 5 Wall Street analysts offering 12 month price targets for Novavax in the last 3 months. The average price target is $19.33 with a high forecast of $29.00 and a low forecast of $10.00. All in all, Novavax stock is a "STRONG BUY" right now.

User Image eennels0157 Posted - 3 hours ago

$NVAX BREAKING NEWS: Côte d’Ivoire will become the first country to roll-out the new R21/Matrix-M™ vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. Every year 600,000 people die of malaria in Africa, according to the World Health Organization (WHO). R21/Matrix-M™ was co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology. In December 2023, the WHO granted R21/Matrix-M™ prequalification status, following a rigorous regulatory process and clinical assessment. Trials also demonstrated that the vaccine was well tolerated, with a good safety profile. In anticipation of the roll-out, the Serum Institute of India has manufactured 25 million doses of the vaccine and is committed to scaling up to 100 million doses annually. https://www.ox.ac.uk/news/2024-07-15-c-te-d-ivoire-makes-history-first-nation-deploy-r21matrix-m-malaria-vaccine

User Image eennels0157 Posted - 3 hours ago

$NVAX BREAKING NEWS_July 23, 2024: NOVAVAX UPDATED COVID-19 VACCINE IS BEING AUTHORIZED AND RECOMMENDED BY QUEBEC'S IMMUNIZATION COMMITTEE!!! https://www.cbc.ca/news/canada/montreal/quebec-renews-covid-19-vaccination-recommendations-1.7272297 With COVID-19 cases on the rise, Quebec's immunization committee has released its recommendations on administering vaccines this fall. In a report published Monday, July 22, 2024, the committee "....is calling on the government to withdraw its preference for mRNA vaccines over Nuvaxovid (Novavax) so that Quebec may recommend the vaccine that "offers protection against variants that are closest to those circulating" and look into offering booster doses along with the flu shot." This recommendations means the Novavax's update vaccine will be in high demand in every hospital, community clinic, doctor's office, and drug store!

User Image eennels0157 Posted - 3 hours ago

$NVAX MORE BIG NEWS IN THE WAY! https://www.cdc.gov/bird-flu/spotlights/h5n1-response-07192024.html

User Image eennels0157 Posted - 3 hours ago

$NVAX

User Image eennels0157 Posted - 3 hours ago

$NVAX "Novavax has expressed confidence in its ability to launch and supply its COVID-19 vaccine for the 2024/2025 season, anticipating a potentially larger market share." Approval will lead to a massive distribution and exponential increase in revenue for the company. https://ir.novavax.com/press-releases/U-S-ACIP-Recommends-Use-of-Authorized-and-Approved-2024-2025-COVID-19-Vaccines Novavax (NVAX) has asked regulators in the U.S. (FDA) and Europe (EMA) to sign off on its updated Covid shot. Noravax is also awaiting approval to distribute its vaccine in Canada. The filing is in line with recommendations that the fall vaccine campaign focuses on the JN.1 variant. Novavax updated shot is active against current circulating strains, including KP.2 and KP.3. Unlike other COVID-19 vaccines, Novavax can be stored in standard refrigeration, enhancing access. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COVID-19. When authorized, Novavax vaccine will be the only protein-based option for aged 12 and older!

User Image Alexxe28 Posted - 3 hours ago

$NVAX https://abcnews.go.com/Health/updated-covid-vaccines-coming-fall/story?id=112299970

User Image eennels0157 Posted - 3 hours ago

$NVAX STRONG CASE FOR APPROVAL OF NOVAVAX UPDATED VACCINE Novavax's Covid vaccine results have shown better tolerability cross-trial than mRNA vaccines (which are associated with greater risk of temporary fever/malaise) and a commercial tie to the established global biotech Sanofi FP flu portfolio of effective vaccines for people of all ages is a significant advantage over the uncertain effectiveness of mRNA flu/Covid combo vaccines. Novavax protein-based approach offers an alternative for people uneasy with the mRNA technology. Sanofi FP is raising consumer awareness of Novavax's better tolerability than (Pfizer's) Comirnaty or (Moderna's) Spikevax. Consumer hesitancy regarding Covid boosters has been driven in part by fears about malaise/fatigue associated with Comirnaty and Spikevax.

User Image eennels0157 Posted - 3 hours ago

$NVAX "Simply put, Novavax's Covid vaccine results have shown better tolerability cross-trial than mRNA vaccines (which are associated with greater risk of temporary fever/malaise) and a commercial tie to the established Sanofi FP flu portfolio of effective vaccines for people of all ages is a significant advantage over the uncertain effectiveness of mRNA flu/Covid combo vaccines." CDC Panel Recommends Novavax: How It Differs From Other Vaccines https://youtu.be/D4lI2SC_lrk?si=kXjM-K1X0mt3Qtg-

User Image Ochaye Posted - 3 hours ago

$NVAX https://www.youtube.com/watch?v=sEj8lUx0gwY My thoughts on NVAX and I'd forgotten how ugly Sullivan was.

User Image eennels0157 Posted - 3 hours ago

$NVAX MONDAY $$$

User Image Alexxe28 Posted - 3 hours ago

$NVAX https://www.forbes.com/sites/davewessner/2024/07/25/covid-outbreak-among-olympic-athletes-serves-as-a-pandemic-reminder/

User Image positive_thinking Posted - 3 hours ago

@wallstbullinfinity $NVAX What this ba$turd said reminds me many trolls in yahoo board!!! "... Investors were scorning, rather than rewarding, foresight. In January 2020 short interest hit 30 per cent, according to S3 Analytics. Even after the company began work on its Covid-19 vaccine, shortseller Citron Research reportedly dismissed it as a “serial promise and non-deliver [er]”. .... " https://www.ft.com/content/22d3805e-c304-4d95-ae32-f559ff34886a

User Image Flowdollas Posted - 3 hours ago

$NVAX Wow!! Celine Dion!! 👑💪🏽🌎 https://www.nbcnews.com/video/celine-dion-performs-during-opening-ceremony-at-the-2024-olympic-games-215778885580

User Image Terramin Posted - 3 hours ago

$NVAX Wait till NVAX gets a surprise grant to make a bird flu vaccine. There are many hidden opportunities here in addition to the Covid vax

User Image hodlmeclose Posted - 4 hours ago

$NVAX H5N1 - if the cdc reports it spreading then this will see $50 again

User Image wallstbullinfinity Posted - 4 hours ago

$INO I posted this 3 years ago to reddit, and it aged well.... "Andrew Left (Citron Research), the mastermind behind Inovio shorting. He attacks EVERY squeeze. He must pay for what he has done to not just Inovio but to MILLIONS of honest small investors. We will take these thieves down ourselves. SEC will intervene when we take action. ILLEGAL SHORTING STOPS NOW" $NVAX $MRNA https://www.reddit.com/r/Inovio/s/cMGuubEgxF

Analyst Ratings
B of A Securities Neutral Jun 14, 24
B. Riley Securities Buy May 23, 24
TD Cowen Hold May 13, 24
HC Wainwright & Co. Buy May 13, 24
B of A Securities Neutral May 10, 24
HC Wainwright & Co. Buy Mar 1, 24
B. Riley Securities Buy Feb 23, 24
HC Wainwright & Co. Buy Aug 10, 23
B. Riley Securities Buy Aug 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dubovsky Filip President, R&D President, R&D Dec 14 Option 5.69 2,833 16,120 55,150 12/18/23
Dubovsky Filip President, R&D President, R&D Nov 05 Option 7.06 1,400 9,884 52,994 11/07/23
Dubovsky Filip President, R&D President, R&D Sep 16 Option 7.71 12,644 97,485 57,702 09/19/23
Trizzino John EVP, CCO and CBO EVP, CCO and CBO Mar 10 Option 6.52 4,609 30,051 11,531 03/14/23
Kelly James Patrick EVP, CFO and Treasur.. EVP, CFO and Treasurer Mar 10 Option 6.52 4,609 30,051 5,832 03/14/23
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Mar 10 Option 6.52 4,609 30,051 13,058 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Buy 7.01 6,000 42,060 14,473 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Option 6.52 6,298 41,063 20,771 03/14/23
YOUNG JAMES F Director Director Mar 31 Sell 74.21 12,500 927,625 62,590 04/04/22
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Sell 197.3 5,000 986,500 2,760 12/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Option 19.08 5,000 95,400 7,760 12/03/21
Glenn Gregory M President, R&D President, R&D Nov 23 Option 19.08 8,250 157,410 12,311 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 23 Sell 200.02 8,250 1,650,165 4,061 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 02 Option 19.08 8,250 157,410 12,311 11/04/21
Glenn Gregory M President, R&D President, R&D Nov 02 Sell 186.83 8,250 1,541,348 4,061 11/04/21
Glenn Gregory M President, R&D President, R&D Oct 26 Option 10.33 11,712 120,985 5,439 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 26 Sell 132.97 10,334 1,374,112 4,061 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 19 Option 19.08 8,250 157,410 12,311 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 19 Sell 166.54 8,250 1,373,955 4,061 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 12 Option 19.08 8,250 157,410 12,311 10/14/21
Glenn Gregory M President, R&D President, R&D Oct 12 Sell 164.07 8,250 1,353,578 4,061 10/14/21
Glenn Gregory M President, R&D President, R&D Jun 17 Option 22.5 10,535 237,038 7,630 06/17/21
Glenn Gregory M President, R&D President, R&D Jun 17 Sell 191.31 8,127 1,554,776 2,811 06/17/21
Glenn Gregory M President, R&D President, R&D Apr 19 Option 61.73 10,531 650,079 7,630 04/19/21
MCMANUS MICHAEL A JR Director Director Mar 23 Sell 220.99 4,000 883,960 5,951 03/23/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Option 21.38 3,404 72,778 670 03/09/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Sell 163.31 3,211 524,388 287 03/09/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Option 26.71 15,022 401,238 15,297 02/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Sell 241.28 15,022 3,624,508 275 02/03/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Option 23.25 13,756 319,827 1,436 01/07/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Sell 114.35 17,913 2,048,352 287 01/07/21
Erck Stanley C President and CEO President and CEO Nov 18 Sell 90.33 52,316 4,725,704 20,495 11/18/20
Erck Stanley C President and CEO President and CEO Nov 18 Option 32.7 52,317 1,710,766 72,811 11/18/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Oct 01 Sell 111.32 2,250 250,470 5,087 10/01/20
Erck Stanley C President and CEO President and CEO Oct 01 Sell 111.71 12,233 1,366,548 20,494 10/01/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Option 5.95 24,750 147,262 43,054 09/30/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Sell 110.91 42,779 4,744,618 275 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Option 5.95 25,000 148,750 46,510 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Sell 110.91 44,949 4,985,295 1,561 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Option 5.95 29,600 176,120 53,008 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Sell 110.86 43,321 4,802,567 7,337 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Option 5.95 50,000 297,500 74,606 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Sell 110.91 29,112 3,228,813 32,727 09/30/20